|
|
||||||||||||||
|
|
|||||||||||||||
Therapeutics |
Key Words: aspirin omeprazole peptic ulcer Helicobacter pylori
| The first 150 words of the full text of this article appear below. |
Design
Randomised {allocation concealed*}
, blinded (clinicians, patients, outcome assessors, monitoring committee, and data analysts),* placebo controlled trial with a median follow up of 12 months.
Setting
A university hospital in Hong Kong, China.
Patients
123 patients who were 1880 years of age (mean age 70 y, 72% men) and had ulcers (gastric, duodenal, or gastroduodenal), were receiving low dose aspirin for >1 month before developing ulcers, had a disease such as stroke or ischaemic heart disease that required long term continuous treatment with low dose aspirin, and had H pylori infection that was objectively diagnosed. Exclusion criteria included oesophagitis; a history of gastric or duodenal surgery other than oversewing of a perforation; allergy to study drugs; H pylori infection that could not be eradicated after 2 attempts with eradication therapies; and concomitant treatment with nonsteroidal anti-inflammatory drugs, corticosteroids, or anticoagulants. Follow up was 92%.
Intervention
After healing of the ulcers and eradication
Colin W Howden, MD
Northwestern University Feinberg School of Medicine
Chicago, Illinois, USA
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |